Dr David Rabbolini
Dr David Rabbolini is a haematologist with extensive expertise in bleeding and thrombotic disorders. He has extensive experience diagnosing and managing individuals with conditions such as venous and arterial thrombotic disorders, bleeding disorders (including haemophilia, von Willebrand disease, and inherited platelet bleeding disorders), immune/autoimmune disorders like ITP, other acquired bleeding disorders and the management of bleeding and thrombotic disorders of pregnancy.
Dr Rabbolini completed a Bachelor of Science (BSc) and Bachelor of Medicine and Surgery (MBBCh) in 2003. He then finished basic physician training at the Royal Brisbane Hospital in 2009. Following advanced training in haematology at the Royal North Shore Hospital, Sydney in 2015, he was awarded dual fellowships with the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA).
With a strong interest in research on bleeding disorders, Dr Rabbolini completed his PhD at the University of Sydney in 2018, focusing on inherited platelet bleeding disorders. He co-founded the Sydney Platelet Group, a research collaborative dedicated to investigating these disorders.
In 2018, Dr Rabbolini undertook a fellowship in transfusion and haemostasis at St Vincent’s Hospital, Sydney. He then served as a staff specialist haematologist at Lismore Base Hospital until the end of 2021 after which he took up a position in the UK as the clinical lead in haemophilia and deep vein thrombosis (DVT) at the Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals in 2022. He returned to Australia in 2023 to establish his practice, where he specialises in providing comprehensive care to individuals with bleeding and clotting disorders.
Referring practitioners can confidently send referrals to Dr Rabbolini for a wide range of non-malignant haematological disorders, including:
• Platelet count anomalies
• Iron metabolism disorders
• Diagnosis and management of thrombotic disorders (venous and arterial)
• Bleeding disorders (including rare coagulation disorders, von Willebrand disease, and suspected platelet function disorders)
• Immune/autoimmune disorders like ITP
• Bleeding disorders in pregnancy
• Acquired bleeding disorders
